Extrapleural Pneumonectomy /Pleurectomy Decortication, IHOC Cisplatin and Gemcitabine With Amifostine and Sodium Thiosulfate Cytoprotection for Resectable Malignant Pleural Mesothelioma

PHASE1CompletedINTERVENTIONAL
Enrollment

141

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

November 30, 2011

Study Completion Date

June 30, 2015

Conditions
Malignant Pleural Mesothelioma
Interventions
PROCEDURE

Extrapleural pneumonectomy (EPP)

Resection of the lung, the lining of the lung (pleura), the covering of the heart (pericardium), and the muscle that separates the chest and abdomen (diaphragm)

DRUG

Cisplatin

Given after the tumor is removed as a bath (perfusion) for one-hour

DRUG

gemcitabine

Given after the tumor is removed as a bath (perfusion) for one-hour

DRUG

amifostine

Given intravenously before perfusion chemotherapy and then 2 hours after the first dose

DRUG

sodium thiosulfate

Given intravenously immediately at the end of perfusion chemotherapy

PROCEDURE

Pleurectomy/Decortication

Resection of the lining of the lung (pleura), while the lung remains intact.

Trial Locations (1)

02115

Brigham and Women's Hospital, Boston

All Listed Sponsors
collaborator

Dana-Farber Cancer Institute

OTHER

lead

Brigham and Women's Hospital

OTHER

NCT00571298 - Extrapleural Pneumonectomy /Pleurectomy Decortication, IHOC Cisplatin and Gemcitabine With Amifostine and Sodium Thiosulfate Cytoprotection for Resectable Malignant Pleural Mesothelioma | Biotech Hunter | Biotech Hunter